Yttrium-90 trans-arterial radioembolization in advanced-stage HCC: The impact of portal vein thrombosis on survival.
Francesco SommaVincenzo StoiaNicola SerraRoberto D'AngeloGianluca GattaFrancesco FiorePublished in: PloS one (2019)
Portal vein invasion does not affect survival in advanced stage HCC-patients undergoing TARE using Y-90 resin-based microspheres. Y90 procedure is associated with regression of portal vein tumor thrombus.